What does this research mean for the field?

Cooperative metabolic mechanisms between platelets and polymorphonuclear leukocytes, specifically involving the lipoxygenase and cyclooxygenase pathways, directly influence platelet adhesion and thrombus formation on the vascular subendothelium. Novelty: ClaimNovelty.INCREMENTAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

To determine how inhibiting platelet and polymorphonuclear leukocyte cyclooxygenase and lipoxygenase pathways alters platelet-subendothelial interactions under dynamic flow conditions.

April 28, 2009Haemostasis

Platelet Adhesivity to Subendothelium Is Influenced by Polymorphonuclear Leukocytes: Studies with Aspirin and Salicylate

View Full Paper

Ask AI

Bookmark

Why the study?

Does treatment with aspirin or salicylate alter platelet-vessel wall interaction and TxB2 production mediated by PMN under flow conditions?

Population

Blood platelets and polymorphonuclear leukocytes (PMN) evaluated in an annular chamber perfusion system

Comparison

Treatment with aspirin and salicylate to inhibit… vs Untreated PMN or platelets

Design

Preclinical

Authors

RHRosa Marı́a HernándezUniversitat de Miguel Hernández d'Elx MAMónica AlemanyInstitut Químic de Sarrià JBJordi BozzoASTER

Discussion

Member takes

Implication

Caution in aspirin dosing for thrombosis; animal data leaves open PMN-platelet cooperation in humans.

Key Points

To determine how inhibiting platelet and polymorphonuclear leukocyte cyclooxygenase and lipoxygenase pathways alters platelet-subendothelial interactions under dynamic flow conditions.
Simulated vascular flow conditions using an annular perfusion chamber system to evaluate cell-vessel wall interactions.
Treated perfusates containing isolated platelets or polymorphonuclear leukocytes (PMN) with aspirin or salicylate to selectively inhibit cyclooxygenase and lipoxygenase pathways.
Quantified cyclooxygenase-derived metabolites, focusing on thromboxane B2 (TxB2) production during perfusion.
Blockade of the PMN lipoxygenase pathway significantly enhanced platelet thrombus formation and increased thromboxane B2 production.
Inhibition of the PMN cyclooxygenase pathway did not alter platelet deposition or thromboxane B2 generation.
Inhibition of platelet cyclooxygenase achieved near-total suppression of thromboxane B2 and enhanced platelet adhesion without modifying thrombus formation.

Structured PICO

Does treatment with aspirin or salicylate alter platelet-vessel wall interaction and TxB2 production mediated by PMN under flow conditions?

Population

Blood platelets and polymorphonuclear leukocytes (PMN) evaluated in an annular chamber perfusion system

Intervention

Treatment with aspirin (ASA) and salicylate (SAL) to inhibit cyclooxygenase and lipoxygenase pathways

Comparator

Untreated PMN or platelets

Outcome

Platelet-vessel wall interaction (platelet adhesion and thrombus formation) and levels of cyclooxygenase-derived metabolites (TxB2) during perfusionsurrogate

Under dynamic flow conditions, cooperative metabolic mechanisms between platelets and PMN directly influence platelet interaction with the vascular subendothelium, which is modulated by aspirin and salicylate.

Cite This Study

Hernández et al. (2009) studied this question.

synapsesocial.com/papers/6a1bdda1ea84844e355f1640 https://doi.org/10.1159/000216845

View Full Paper

Ask AI

Bookmark

Platelet Adhesivity to Subendothelium Is Influenced by Polymorphonuclear Leukocytes: Studies with Aspirin and Salicylate

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Platelet Adhesivity to Subendothelium Is Influenced by Polymorphonuclear Leukocytes: Studies with Aspirin and Salicylate

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Also Consider

Also Consider